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Abstract
Background: Mediation analysis tests whether the relationship between two variables is explained by a third
intermediate variable. We sought to describe the usage and reporting of mediation analysis with time-to-event
outcomes in published healthcare research.
Methods: A systematic search of Medline, Embase, and Web of Science was executed in December 2016 to
identify applications of mediation analysis to healthcare research involving a clinically relevant time-to-event
outcome. We summarized usage over time and reporting of important methodological characteristics.
Results: We included 149 primary studies, published from 1997 to 2016. Most studies were published after 2011
(n = 110, 74%), and the annual number of studies nearly doubled in the last year (from n = 21 to n = 40). A
traditional approach (causal steps or change in coefficient) was most commonly taken (n = 87, 58%), and the
majority of studies (n = 114, 77%) used a Cox Proportional Hazards regression for the outcome. Few studies (n = 52,
35%) mentioned any of the assumptions or limitations fundamental to a causal interpretation of mediation analysis.
Conclusion: There is increasing use of mediation analysis with time-to-event outcomes. Current usage is limited by
reliance on traditional methods and the Cox Proportional Hazards model, as well as low rates of reporting of
underlying assumptions. There is a need for formal criteria to aid authors, reviewers, and readers reporting or
appraising such studies.
Keywords: Mediation, Indirect effect, Counterfactuals, Reporting, Mediation analysis, Survival, Time-to-event,
Methodology
Background
Mediator variables lie along the causal pathway between
an independent and dependent variable, explaining all or
part of the effect of the independent variable on the
dependent variable [1]. While mediation analysis has
been prominently featured in social science research,
this methodology is now gaining popularity in healthcare
research. It is used primarily for two purposes: to under-
stand how certain relationships (including treatment
effects) occur, and to identify possible targets for future
interventions [1]. A test of mediation examines whether
the effect of the independent variable (x) on the
dependent variable (y) occurs via a third, intervening
variable (z) (see Figs. 1, 2). This basic structure – re-
ferred to as a single-mediator model – can be expanded
to include additional considerations such as multiple
mediators and moderated mediation [2–5].
The causal interpretation implicit in any mediation
analysis rests on a number of untestable assumptions,
which are often underreported in published research
[6, 7]. In particular, the sequential ignorability
assumption states that there is no unmeasured con-
founding of the exposure-mediator, mediator-outcome, or
exposure-outcome relationships [8]. Furthermore, there
must be no confounders (measured or unmeasured) of
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the mediator-outcome that depend on the exposure
[9–11]. While these assumptions can theoretically be
satisfied by random allocation, it is not possible to
randomise both exposure and mediator [12]. As a conse-
quence, some suggest that any mediation analysis be
accompanied by sensitivity analyses to investigate the ro-
bustness of findings to violations of this crucial assump-
tion [8]. Furthermore, tests of mediation assume that the
mediator has been appropriately defined and measured
[13]. In addition to these fundamental assumptions, the
temporal sequence of independent variable, mediator, and
dependent variable should support the argument for
causation [14, 15].
Traditional methods of mediation analysis include
fulfilling a series of stepwise criteria (causal steps), as
proposed by Baron and Kenny in 1986 [16]. To quantify
the degree of mediation, simple formulas combine par-
ameter estimates obtained from a series of regressions
[1, 17, 18]. The resulting difference and product tests
were originally intended for linear relationships with
continuous outcomes such as blood pressure, but have
been adapted for binary outcomes such as mortality. Un-
fortunately these methods are ill-adapted to non-normally
distributed continuous and/or censored variables, such as
time-to-event outcomes [14].
Mortality and survival time are a major focus in
healthcare research. Survival analysis allows investigators
to study these important outcomes with appropriate
consideration for variable follow-up times, censoring,
and competing risks. Cox Proportional Hazards (PH)
Fig. 1 Causal diagram depicting the relationship between independent (x), dependent (y), and mediator (z) variables
Fig. 2 An example of mediation analysis in healthcare research
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regression is commonly used for such analyses, yet its
use in mediation analysis poses some important
challenges. The semi-parametric Cox model builds on
proportionality of the hazards. Proportionality is violated
when adding an additional (mediator) variable to a
correctly specified Cox regression model. This addition
could shift the baseline hazards up or down, rather than
only altering the slope of the hazard function [19]. Stat-
isticians term this phenomenon the “non-collapsibility”
of the hazard ratio [20]. As a result, parameter estimates
obtained with and without a mediator cannot be mean-
ingfully compared as they might be in a linear model
[21, 22]. This problem is exacerbated as the outcome
frequency rises. Thus, use of Cox PH regression to
approximately estimate indirect effects via difference or
product of coefficients rests on the assumption that the
outcome is rare [21]. Parametric survival (including
accelerated failure time) and additive hazard models do
not have this limitation [14, 21]. These models provide
readily interpretable outcome measures (expressed as
hazard ratios or differences), yet they are less familiar to
clinical researchers than the popular Cox model [14].
Path analysis provides another possible approach, and
allows for modelling of the relationships between a large
number of confounding and mediator variables [23].
Structural Equation Modelling (SEM) is derived from
path analysis, and incorporates latent variables, allowing
uncertainty of variable measurement to be incorporated
into the analysis [23]. Using SEM and path analysis, rela-
tionships can be deconstructed into subcomponents and
indirect effects obtained [24]. Although these models
depend on linearity of relationships, time-to-event out-
comes can be modelled in SEM and path using discrete
time survival analysis or dynamic path analysis, wherein
the follow-up period is broken down into short time
intervals [25–28]. Such methods allow mediation effects
to be expressed as hazard ratios and hazard differences,
respectively. Drawing conclusions based on results of
SEM and path analysis depends on adequate linear
model specification, and that all included variables are
free of unmeasured confounding [29].
As a result of the linearity assumptions inherent to
previous methods of mediation analysis, alternative
methods have been sought. The counterfactual or poten-
tial outcomes approach evolved more recently from the
literature on causal inference [30]. In this framework,
mediation analysis is treated as a problem of missing
data, and observed and unobserved potential outcomes
are modelled. This flexible approach can accommodate
any data distribution, and be applied to any type of me-
diator or outcome variable, including time-to-event [8].
In addition to meeting the assumptions underlying a
causal interpretation of mediation analysis, implementa-
tion of this approach requires meeting the assumptions
inherent to any selected models. Within the counterfac-
tual framework, additive hazard, parametric survival and
marginal structural models also allow for measurement
of indirect effects, without the limitation to rare out-
comes [31].
While the above approaches offer a range of strategies
to address mediation analysis with a time-to-event out-
come, some require advanced statistical coding, or at
least an understanding of counterfactual concepts. While
mediation analysis is increasingly utilized, we do not
know how healthcare researchers have addressed this
problem. Although others have described the recent
reporting of causal mediation analysis, they have not
examined practices specific to time-to-event outcomes,
nor have they described temporal trends in the use of
these methods [6, 7]. We sought to evaluate the usage
and reporting of mediation analysis with time-to-event
outcomes in all published healthcare research.
Methods
Systematic search and screening
A systematic and sensitive search strategy, developed
with a research librarian (AOC), was used to identify
published articles employing mediation analysis with a
time-to-event outcome. The search strategy was initially
developed for Ovid Medline, and then customized for
use in the other databases. At the time of the search,
specific subject headings for mediation analysis and
time-to-event were unavailable in the databases used. As
a result, the strategy was devised using an extensive list
of appropriate text words and phrases mined from sam-
ple articles and through input from subject specialists
on the team. Ovid Medline, Ovid Medline Epub Ahead
of Print and In-Process & Other Non-Indexed Citations,
and Ovid Embase were searched from inception to date
of search. All searches were executed between December
9th and 12th, 2016. No limits for date were applied and
animal-only studies were excluded where applicable.
Book and conference materials were also excluded from
Embase. In addition, cited reference searches were
conducted in the Web of Science Core Collection for
any articles citing one of five highly cited and relevant
methodological articles [8, 31–34] (see Additional file 1
for details of search).
Studies relating to human healthcare, with an empiric
application of mediation analysis and a clinically relevant
time-to-event outcome, were selected for inclusion.
Since we were most interested in how a non-specialist
healthcare researcher applied the methodology, theoret-
ical papers with an illustrative application were excluded.
Review articles were manually searched for relevant
primary studies.
Inclusion criteria were pre-specified and refined after
pilot screening of 10 full-text articles. Specifically,
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inclusion criteria were refined to include a formal test of
mediation, in the form of meeting specific listed criteria
(e.g. directly cite Baron and Kenny or describe causal
steps methodology), a statistical test with a p-value, or a
measurement of indirect effect/proportion mediated.
This was necessary as many studies did not set out to
assess mediation, but mentioned it as a possible explan-
ation for weakening of an observed association upon the
introduction of other variables.
All eligible abstracts were screened in duplicate by
LLS and ZB. Abstracts deemed eligible by either LLS or
ZB were included for full-text review. All full texts were
screened by LLS. Uncertainty in study inclusion or ex-
traction was addressed by discussion with TL, a meth-
odological expert. NAH performed duplicate full-text
screening and extraction of a 10% random sample (n =
33) in order to assess reproducibility.
Duplicate screening showed 82% agreement, Cohen’s
kappa was 0.63 (95% CI 0.36–0.89). Disagreements
related to the relevance of a clinical outcome (sick leave,
n = 1, study was included) and whether a formal test of
mediation was described (n = 5, all excluded). Though
these five excluded studies did not explicitly state how
they assessed mediation or indirect effects, they ap-
peared to use the following strategies: partial causal
steps (n = 1), change in coefficient (n = 4). They all used
Cox PH models for the outcome, and none mentioned
any of the assumptions fundamental to mediation
analysis.
Extraction
The criteria for extraction were developed in consider-
ation of the STROBE statement [35], existing systematic
reviews of mediation analysis [6, 7, 36], and methodo-
logical concerns unique to time-to-event outcomes.
After a pilot extraction from 10 full-text articles,
extraction criteria were refined and all extraction per-
formed by LLS. Where studies included a methodo-
logical supplement for mediation details, these were also
reviewed for relevant information. The results of dupli-
cate extraction from a 10% random sample of included
studies are presented in Table 1. The criteria tested for
inter-rater reliability were pre-specified based on their
importance. Estimates of Cohen’s kappa (with 95%
confidence intervals) were obtained using the “kappa2”
function in the “irr” package in R [37].
We extracted information on study characteristics in-
cluding methodological approach to mediation analysis,
statistical analysis, assumptions addressed, and measures
reported. Results are presented as counts and frequen-
cies for categorical or binary characteristics, and as
median and interquartile range for study sample size.
As suggested by a peer reviewer, we added selected
comparisons of studies published before or after 2013.
Comparisons were made with the Chi-square test, with
p < 0.05 defined as significant; Fischer’s exact text was
used for comparisons where frequencies of 0 (empty
cells) were reported.
Results
Our search yielded 1991 unique abstracts, of which 321
were selected for further review (see Fig. 3). Of these, 8
were excluded as they did not relate to human
healthcare, 110 because they did not include mediation
criteria, test, or measurement of the indirect effect/pro-
portion mediated. Another 12 were excluded because
they did not include a clinically meaningful outcome,
and 41 because the outcome of mediation analysis was
not time-to-event. Further, one full text could not be
reviewed as it was in Arabic. This left 149 studies eligible
for extraction (see Additional file 2 for the list of
included studies).
The earliest study was published in 1997, and there
were fewer than 10 studies per year up to 2011. There
were 110 included studies (74%) published in 2012 or
later, and the number of studies nearly doubled from
2015 to 2016 (n = 21 in 2015, n = 40 in 2016, see Fig. 4).
Over half of included studies had a first author based in
the United States (n = 77, 51%), and 82 were from North
America (55%). Otherwise, 55 (37%) publications
originated in Europe, 5 (3%) were from Asia, 5 (3%)
from Australia, 1 (< 1%) was from Israel and 1 (< 1%)
from Brazil. Sixty-four individuals were listed as an
author on more than one included study. The number
of studies per author ranged from 1 to 6, with 8 individ-
uals listed on 5 or more studies. Included studies most
commonly came from journals in the areas of epidemi-
ology (n = 37, 25%), psychology/psychiatry (n = 19, 13%),
cardiology (n = 17, 11%), oncology (n = 13, 9%), and
general medicine (n = 13, 9%). Eleven studies (7%) were
published in high impact journals (impact factor 10 or
greater) [38].
Mediation analysis was in most cases (n = 80, 54%) not
the primary study aim, and was frequently an
exploratory analysis (n = 74, 50%, see Table 2). Many
studies (n = 76, 51%) tested multiple mediators. The
most commonly tested mediators were psychological or
psychiatric (n = 32, 21%), physiologic parameters (n = 34,
23%) or lifestyle factors (n = 31, 21%). The majority of me-
diators were continuous (n = 60, 40%) or binary (n = 56,
38%) variables. The most common outcome was the onset
of a new medical condition or exacerbation of an existing
condition (n = 68, 46%). A causal diagram was included in
a third (n = 59, 40%) of studies. Results supporting a medi-
ation model were reported in 130 studies (87%), and 19
studies (13%) reported that all tested mediators either did
not meet criteria or were statistically not significant.
Sixty-four studies (43%) reported mixed results (both
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significant and not significant) for the various mediators
being tested.
The most common method used for mediation
analysis was comparing coefficients (henceforth known
as “change in coefficient”) before and after a mediator
was introduced into an exposure-outcome regression
model without testing the other relationships included
in the causal steps approach (n = 46, 31%). Other com-
monly used methods included causal steps (n = 41, 28%),
counterfactuals (n = 32, 21%) and SEM or path analysis
(n = 23, 15%). Studies published prior to 2010 predomin-
antly featured causal steps and SEM/path approaches.
After 2011, there was increased use of counterfactuals,
change in coefficient, and causal steps methods of medi-
ation analysis (see Fig. 5).
The majority (n = 136, 91%) of included studies
described their funding source. In most cases (n = 113,
76%) this was governmental. The majority of included
applications were cohort studies (n = 131, 88%). Most
studies (n = 112, 75%) did not report exposure, mediator
and outcomes that were clearly separated and sequential
in time. Most commonly, overlap occurred in measure-
ment of exposure and mediator (n = 89, 60%). The most
common method used to deal with confounding of
exposure and mediator was regression (n = 137, 92% for
exposure; n = 138, 93% for mediator). Most studies did
not mention any of the assumptions underlying
mediation analysis (n = 97, 65%), a third (n = 52, 35%)
mentioned at least one assumption, and eight (5%)
mentioned all the assumptions. Among studies with a
primary aim to assess mediation (n = 69), 33 (48%) men-
tioned one or more assumption, and six (9%) mentioned
all assumptions. Sensitivity analysis relating to mediation
analysis was included in 25 studies (17%).
Of 105 studies with outcomes other than all-cause
mortality, four (4%) included consideration of competing
risks. Of 35 studies with possible clustering of data in
the exposure or mediator, 19 (54%) addressed this in
their analysis. A third of studies (n = 46, 31%) mentioned
or tested for interaction between exposure and mediator.
Table 1 Agreement on important characteristics, at re-extraction of a 10% random sample of included studies
Characteristic Unweighted Cohen’s Kappa (95% CI)
Funding source 0.75 (0.5–1)
Study Design 0.65 (0.02–1)
Type of analysis (confirmatory/hypothesis-based versus exploratory) 0.14 (0–0.5)
Mediation analysis is primary aim of study 0.52 (0.12–0.92)
Causal diagram included 1 (1–1)
Sample size 0.75 (0.55–0.96)
Power/sample size calculation included 0 (unable to estimate, too infrequent)
Method of mediation analysis 0.84 (0.83–1)
Type of time-to-event model 0.91 (0.75–1)
Competing risks considered 0 (unable to estimate, too infrequent)
If clustering of data, was this addressed in the analysis? 0.61 (0.15–1.0)
Outcome frequency > =10% 0.79 (0.54–1)
Rare outcome limitation for Cox model mentioned Unable to estimate, all false (100% agreement)
Temporal separation clearly defined 0.76 (0.47–1)
No unmeasured confounding of exposure/outcome 0.82 (0.49–1)
No unmeasured confounding of mediator/outcome 0.85 (0.57–1)
No unmeasured confounding of exposure/mediator 0.6 (0.13–1)
No exposure-dependent confounding of mediator-outcome 0.64 (0–1)
Accurate measurement of mediator 0.65 (0.32–0.99)
Interaction between exposure and mediator considered/tested 0.6 (0.19–1)
Was a method used to address confounding of exposure or mediator? N/A (100% used regression for both exposure and mediator, 100% agreement)
Sensitivity analysis relating to mediation analysis 0.44 (0.05–0.75)
Measures reported-indirect effect 0.76 (0.46–1)
Measures reported- proportion mediated 0.86 (0.61–1)
Precision estimate for indirect effect 1.0 (N/A)
Precision estimate for proportion mediated 0.77 (0.34–1)
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Sample sizes ranged from 23 to 2,940,453, with 10
studies (7%) reporting sample sizes below 200. A single
study included a sample size calculation, in this case for
the association between the exposure and mediator [39],
and another three studies discussed power and sample
size as they relate to mediation. Software packages
specifically used for mediation were mentioned in 32
studies (21%).
Indirect effect was reported in 55 studies (37%),
proportion mediated in 83 studies (56%); 38 studies
Fig. 4 Included studies, by year of publication
Fig. 3 PRISMA Flow Diagram
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Table 2 Characteristics of mediation analyses with time-to-event
outcome in healthcare research, n = 149
Included study characteristic Result
Funding source, n (%)
Government 113 (76)
Foundation 37 (25)
Hospital 6 (4)
Industry 6 (4)
University 4 (3)
Professional association 1 (< 1)
None stated 13 (9)
Study design, n (%)
Cohort 131 (88)
Randomised Controlled Trial 8 (5)
Case-cohort 5 (3)
Case control 4 (3)
Cross-sectional 1 (< 1)
Type of analysis, n (%)
Confirmatory/Hypothesis-based 72 (48)
Exploratory 74 (50)
Not able to infer 3 (2)
Mediation analysis is primary aim of study, n (%) 69 (46)
Multiple mediators tested, n (%) 76 (51)
Type of mediator, n (%)
Continuous 60 (40)
Binary 56 (38)
Categorical 25 (17)
Interval/Ordinal 25 (17)
Latent 8 (5)
Most common content of mediatora, n (%)
Physiologic (e.g. blood pressure, heart rate, weight) 34 (23)
Psychological/psychiatric 32 (21)
Lifestyle (e.g. alcohol, smoking, nutrition,
exercise, sleep)
31 (21)
Biomarker (blood test results) 24 (16)
Health 17 (11)
Comorbidity 13 (9)
Treatment 8 (5)
Functioning 8 (5)
Socioeconomic 8 (5)
Environment 6 (4)
Reproductive 2 (1)
Most common outcomes, n (%)
New medical condition or exacerbation
of an
existing condition
68 (46)
All-cause mortality 48 (32)
Table 2 Characteristics of mediation analyses with time-to-event
outcome in healthcare research, n = 149 (Continued)
Included study characteristic Result
Cause-specific mortality 21 (14)
Disability or sick leave 6 (4)
Causal diagram included, n (%)
Causal steps/change in coefficient (n = 87) 22 (25)
Counterfactuals (n = 32) 16 (50)
SEM/path (n = 23) 18 (78)
Product of coefficients (n = 6) 3 (50)
Cannot infer (n = 1) 0 (0)
Sample size, median (IQR) 3345 (637–16,061)
Power/sample size, n (%)
Calculation 1 (< 1)
Consideration 3 (2)
Method of mediation analysis, n (%)
Causal steps, including Baron-Kenny 41 (28)
Change in coefficient in a single regression 46 (31)
Counterfactuals 32 (21)
SEM/path 23 (15)
Product of coefficients 6 (4)
Cannot infer 1 (< 1)
Statistical tests for no mediation/indirect effect, n (%)
Sobel 7 (5)
Other product test 14 (9)
Difference test 2 (1)
Z-test of mediated proportion 1 (< 1)
Joint significance test 1 (< 1)
Olaf & Finn test 1 (< 1)
Type of time-to-event model, n (%)
Cox proportional hazard 114 (77)
Additive hazard 10 (7)
Linear 7 (5)
Discrete time survival model 6 (4)
Failure time/parametric survival 5 (3)
Marginal structural model 3 (2)
Log linear Poisson 1 (< 1)
Quantile regression 1 (< 1)
Cannot infer 5 (3)
Specific mediation software mentioned, n
Causal steps/change in coefficient
SAS “mediate” macro 2
PRODCLIN 1
Counterfactuals
R 8
R “mediation” 2
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Table 2 Characteristics of mediation analyses with time-to-event
outcome in healthcare research, n = 149 (Continued)
Included study characteristic Result
SAS 1
SAS “mediate” macro 1
STATA “medeff” 1
SEM/path
Mplus 13
SAS 1
STATA mediation package 1
LISREL 1
Competing risks considered, n (%) 4 (3)
If clustering of data, was this addressed in the
analysis? n (%)
Not multilevel 114
Yes 19 (54)
No 8 (23)
Cannot determine 8 (23)
Cox models, outcome frequencyb, n (%)
> or equal to 5% 74 (65)
> or equal to 10% 55 (48)
Rare outcome limitation for Cox model mentionedb,
n (%)
8 (7)
Temporal separation clearly defined, n (%)
Yes 37 (25)
Overlap exposure and mediator 89 (60)
Overlap mediator/outcome 7 (5)
Cannot determine 19 (13)
Acknowledged as a limitation 20 (13)
Mediation assumptions (or limitation) stated, n (%)
No unmeasured confounding of
exposure/outcome
29 (19)
No unmeasured confounding of
mediator/outcome
29 (19)
No unmeasured confounding of
exposure/mediator
22 (15)
No exposure-dependent confounding of
mediator-outcome
17 (11)
Accurate measurement of mediator 31 (21)
Interaction between exposure and mediator
considered/tested, n (%)
46 (31)
Method to address confounding of exposure
(more than one can be used), n (%)
Regression/modelling 137 (92)
Stratification/restriction 14 (9)
Randomisation 6 (4)
None 9 (6)
Method to address confounding of mediator
(more than one can be used), n (%)
Regression/modelling 138 (93)
Table 2 Characteristics of mediation analyses with time-to-event
outcome in healthcare research, n = 149 (Continued)
Included study characteristic Result
Weighting 13 (9)
Stratification/restriction 13 (9)
Matching 1 (< 1)
None 10 (7)
Sensitivity analysis related to mediation analysis, n (%)
Any 25 (17)
Confounding 8 (5)
Accurate measurement/specification of mediator 7 (5)
Temporal sequence assumption 6 (4)
Testing a combined mediator or all mediators in
same model
5 (3)
Interaction/moderation 2 (1)
Measures of mediation reported, n (%)
Causal steps/change in coefficient method (n = 87)
Indirect effect 7 (8)
Proportion mediated 52 (60)
Counterfactuals (n = 32)
Indirect effect 29 (91)
Proportion mediated 22 (69)
SEM/path (n = 23)
Indirect effect 16 (70)
Proportion mediated 5 (22)
Other (n = 7)
Indirect effect 3
Proportion mediated 4
Measures of precision reported, n (%)
Causal steps/change in coefficient (n = 87)
Indirect effect confidence interval 6 (7)
Proportion mediated confidence interval 17 (20)
Statistical test p-value or equivalent 10 (11)
Counterfactuals (n = 32)
Indirect effect confidence interval 29 (91)
Proportion mediated confidence interval 14 (44)
SEM/path (n = 23)
Indirect effect confidence interval 15 (65)
Proportion mediated confidence interval 2 (9)
Statistical test p-value or equivalent 4 (17)
Other (n = 7)
Indirect effect confidence interval 3
Proportion mediated confidence interval 3
Statistical test p-value or equivalent 2
aTotal exceeds 100% because of multiple mediators in many studies
bDenominator is 114
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(26%) did not report either of these. Most studies report-
ing an indirect effect size included a measure of uncer-
tainty (n = 53 of 55, 96%) around the estimate; however,
only 36 studies (of 83, 43%) included a measure of
uncertainty around the proportion mediated. A total of
16 studies (11%) included a test p-value, for the null
hypothesis of no mediation.
The time-to-event outcome was most commonly
modelled using a Cox PH model (n = 114, 77%). Only
7% (n = 8) of these included any mention of the rare out-
comes assumption underlying use of this model. Of the
55 studies with a Cox PH model and an outcome fre-
quency greater than 10%, 33 (60%) reported an estimate
for either the indirect effect or the proportion mediated.
There were 49 studies published from 1997 to 2012,
and 100 studies published from 2013 to 2016. More
recently published studies were more likely to include
measures of the indirect effect or proportion medi-
ated (80% vs 63%, p = 0.03), a measure of precision
such as a p-value or 95% CI (69% vs 45%, p = 0.005),
and a sensitivity analysis relating to mediation (21%
vs 8%, p = 0.049). In contrast, more recently published
studies were not significantly more likely to contain
mention of any (66% vs 63%, p = 0.7) or all assump-
tions (8% vs 0%, p = 0.053) underlying causal medi-
ation analysis.
Discussion
We studied the use and reporting of mediation analysis
with a time-to-event outcome in healthcare research.
We found that the use of mediation analysis with
time-to-event outcomes increased over time and crossed
multiple clinical fields. The most common time-to-event
outcomes were the onset or exacerbation of a medical
condition, and the most common mediators were physio-
logic, psychological or lifestyle factors. This suggests that
researchers are most interested in understanding whether
specific patient-related factors explain disease onset.
Although included studies were a mix of exploratory and
confirmatory/hypothesis-based, over half of included
studies did not have mediation analysis as the primary
aim. This indicates that mediation analysis is often used as
an adjunct to help understand the findings of a primary
research question. There were several instances of
repeated authorship. This suggests further mechanistic
exploration following an early discovery (for example, the
research into premature death in the visually impaired, by
Christ, Zheng, Lee and Lam [40–43]) as well as spread of
the tools of mediation by a few highly collaborative
methodological experts.
Included healthcare studies covered a broad range of
mediation analysis practices. The majority of mediation
analyses were undertaken using traditional methods
(change in coefficient or causal steps). While the publi-
cation of seminal methodological articles in 2010–2012
can explain the growth in the number of studies using a
counterfactual approach, the concurrent rise in use of
traditional approaches suggests heightened awareness of
broad mediation concepts among clinical researchers.
Many researchers may prefer traditional approaches due
to their intuitive appeal and easy implementation.
A minority of studies reported or discussed the
assumptions underlying causal interpretations of medi-
ation analysis, as described by others [7]. Many studies
measured exposures and mediators simultaneously at
baseline. When the mediator does not occur after the
exposure, this weakens the argument for causation. Few
studies mentioned assumptions relating to confounding,
or accurate measurement of the mediator. When
underlying assumptions go unmentioned, readers may
mistakenly believe causal conclusions to be more robust
than they actually are.
Fig. 5 Included studies by year, according to their approach to mediation analysis
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Most studies in our review used Cox PH regression to
model a time-to-event outcome. In such cases, obtaining
an estimate of the indirect effect depends on the outcome
being rare. Where the outcome is common, measures of
the indirect effect or proportion mediated will be incorrect
[20]. Yet, Cox Proportional Hazards were often used to
model a common outcome, and nearly two thirds of such
studies reported one or both of these measures. Further,
the rare outcome assumption was infrequently mentioned.
Our study identifies further details on current research
practices. While regression methods were frequently used to
adjust for baseline characteristics (potential confounders),
few studies included any form of sensitivity analysis relating
to mediation. Interaction of the exposure and mediator was
most often not considered. A minority of studies addressed
competing risks, which alter the interpretation of mediated
effects where the outcome is other than all-cause mortality.
Specifically, reported effects are only valid for the population
that remains alive. Although sample sizes were generally
large, only one study attempted to justify sample size,
despite the existence of programs designed for this
purpose [44, 45].
Although recent studies were more likely to include
effect sizes, measures of precision (p-values or confi-
dence intervals) and sensitivity analyses, reporting of
characteristics and results of mediation analyses was
overall suboptimal. The deficiencies identified in our
study underscore the importance of developing standard
reporting criteria for mediation analysis. Although others
have made recommendations, no formal criteria have
been published [7]. In addition to meeting established
criteria for observational studies [35], we recommend
that studies of mediation report the following items (see
Table 3): whether mediation analysis is exploratory or
confirmatory/hypothesis-based; the criteria used to assess
mediation; the timing, measurement, and specification of
exposure, mediator(s) and outcome variables; the type of
model(s) and statistical software used; and methods used
to account for any clustering or interactions between ex-
posure and mediator. In addition, results reported should
be accompanied by measures of precision (95% confidence
intervals). Interpretation of the mediated effect should be
made in the context of any competing risks (e.g.
cause-specific indirect effect, among those who have not
yet been censored). Assumptions underlying mediation
analysis, and strategies used (regression, propensity scores,
sensitivity analysis) to meet or test those assumptions
should be detailed [9, 15]. Finally, the extent to which
such assumptions limit causal inferences should be
discussed in the limitations section.
We further recommend that researchers seeking to
measure the degree of mediation or indirect effects avoid
using a Cox PH model when the outcome is common (oc-
curs in more than 10% of subjects). We suggest employing
a counterfactual-based approach, which allows for media-
tors and outcomes of varied data distribution. Within this
framework, the scale on which mediation is measured
(hazard ratios, hazard differences) should be dictated by
Table 3 Reporting recommendations for mediation analysis with a time-to-event outcome
Section Recommendation
Objectives State whether mediation analysis(es) is/are exploratory or hypothesis-based
Methods Specify criteria or statistical tests used to assess mediation, with references
Was the goal to categorize mediation as absent, partial or complete, or to estimate exact values for direct and
indirect effects?
Detail how exposure, mediator and outcome variables were defined and measured
Detail when exposure, mediator and outcome variables were measured
Describe statistical models used for the mediator(s) and outcome(s), and any assumptions underlying use of
such models (e.g. proportionality, rare outcome assumption for Cox Proportional Hazards models)
State whether interaction between exposure and mediator was considered, and how
Reference any software programs used for mediation analysis
If relevant for exposure, mediator, and outcome being considered, state how the following were addressed:
- clustering or repeated events
- competing risks
Describe assumptions underlying mediation analysis, and methods used to address these (e.g.: randomisation,
regression, weighting, stratification, sensitivity analysis)
Results Report measures of mediation effect (indirect effect or proportion mediated) accompanied by 95% confidence
intervals
Report p-values for mediation hypothesis testing
Discussion Discuss limitations of causal inference based on mediation analysis results, including whether underlying
assumptions were met
Discuss magnitude and direction of any potential bias
In addition to these, mediation analyses should meet the STROBE criteria for observational studies [35]
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the medical problem at hand. Marginal structural, additive
hazards and parametric survival models can be used when
the outcome is common (> 10%). If familiarity and ease of
implementation strongly favours a Cox-based approach,
then authors must confirm that the outcome is rare.
Strengths of our study include its systematic search of
multiple databases, and pre-defined extraction criteria.
Further, previous systematic reviews of mediation analysis
have been limited to specific journals or studies published
in 2015 [6, 7]. While we were focused on mediation ana-
lysis with a time-to-event outcome, our inclusion of all
methodological approaches over a long time frame has
better illustrated the evolution of real-world research
practices with this emerging methodology.
This study has several limitations. First, mediation
analysis and time-to-event did not have specific index
terms available in the databases searched, and thus we
relied on keyword searching to identify eligible studies.
We mitigated this by using a broad range of terms to
maximize sensitivity. Second, our findings are limited to
published studies. However, this was intentional as we
were interested in understanding which practices would
be accepted in the peer-reviewed literature. Third, it is
possible that authors are not reporting their full ap-
proach to mediation analysis due to space limitations.
This underscores the need for standard reporting
criteria, in order to help authors, reviewers, and editors
prioritize content.
Conclusions
Mediation analysis for time-to-event outcomes is being
used with increasing frequency by researchers around the
world. There is ongoing reliance on traditional methods
such as causal steps and change in coefficient. When com-
bined with Cox PH modelling, these methods are limited
to use with rare outcomes. As a result, methods using
counterfactuals and/or alternative survival models are pre-
ferred. We provide preliminary criteria that may be used
by researchers reporting or reviewing similar studies.
However, as mediation analysis is increasingly used in
clinical research, a comprehensive set of reporting criteria
must be more formally developed, with input from clini-
cians, healthcare researchers, journal editors and meth-
odological experts. Such criteria will greatly benefit
researchers seeking to report not only the “why” but also
the “how” of their findings.
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